Tuesday 21 August 2018 ,
Tuesday 21 August 2018 ,
Latest News
  • Road crashes claim 15 lives in Narsingdi, Feni
  • 52 Bangladeshis pilgrims have so far died in Saudi
  • Safe road movement: 9 more students freed from Keraniganj jail
  • Khalishpur Meghna oil depot catches fire, 3 killed
  • Truck-microbus collision kills 6 in Feni
  • Myanmar tactfully delaying Rohingya repatriation
  • Movement for safe roads: 25 students get bail
5 February, 2018 00:00 00 AM

WHO on cancer

WHO on cancer

Key facts
•    Cancer is one of the leading causes of morbidity and mortality worldwide, with
approximately 14 million new cases in 2012.
•    The number of new cases is expected to rise by about 70% over the next 2 decades.
•    Cancer is the second leading cause of death globally, and was responsible for 8.8
million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer.
•    Approximately 70% of deaths from cancer occur in low- and middle-income countries.
•    Around one third of deaths from cancer are due to the 5 leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, and alcohol use.
•    Tobacco use is the most important risk factor for cancer and is responsible for approximately 22% of cancer deaths.
•    Cancer causing infections, such as hepatitis and human papilloma virus (HPV), are responsible for up to 25% of cancer cases in low- and middle-income countries.
•    Late-stage presentation and inaccessible diagnosis and treatment are common. In 2015, only 35% of low-income countries reported having pathology services generally available in the public sector. More than 90% of high-income countries reported treatment services are available compared to less than 30% of low-income countries.
•    The economic impact of cancer is significant and is increasing. The total annual economic cost of cancer in 2010 was estimated at approximately US$ 1.16 trillion.
•    Only 1 in 5 low- and middle-income countries have the necessary data to drive cancer policy.


Cancer is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumours and neoplasms. One defining feature of cancer is the rapid

creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs, the latter process is referred to as

metastasizing. Metastases are a major cause of death from cancer.

The problem

Cancer is a leading cause of death worldwide, accounting for 8.8 million deaths in 2015. The most common causes of cancer death are cancers of:

Lung (1.69 million deaths)

Liver (788 000 deaths)

Colorectal (774 000 deaths)

Stomach (754 000 deaths)

Breast (571 000 deaths)

What causes cancer?

Cancer arises from the transformation of normal cells into tumour cells in a multistage process that generally progresses from a pre-cancerous lesion to a malignant tumour.

These changes are the result of the interaction between a person's genetic factors and 3 categories of external agents, including:

physical carcinogens, such as ultraviolet and ionizing radiation;

chemical carcinogens, such as asbestos, components of tobacco smoke, aflatoxin (a food contaminant), and arsenic (a drinking water contaminant); and

biological carcinogens, such as infections from certain viruses, bacteria, or parasites.

WHO, through its cancer research agency, International Agency for Research on Cancer (IARC), maintains a classification of cancer-causing agents.

Ageing is another fundamental factor for the development of cancer. The incidence of cancer rises dramatically with age, most likely due to a build-up of risks for specific cancers that increase with age. The overall risk accumulation is combined with the tendency for cellular repair mechanisms to be less effective as a person grows older.

Risk factors for cancers

Tobacco use, alcohol use, unhealthy diet, and physical inactivity are major cancer risk factors worldwide and are also the 4 shared risk factors for other noncommunicable diseases.

Some chronic infections are risk factors for cancer and have major relevance in low- and middle-income countries. Approximately 15% of cancers diagnosed in 2012 were attributed to carcinogenic infections, including Helicobacter pylori, Human papillomavirus (HPV), Hepatitis B virus, Hepatitis C virus, and Epstein-Barr virus.

Hepatitis B and C virus and some types of HPV increase the risk for liver and cervical cancer, respectively. Infection with HIV substantially increases the risk of cancers such as cervical cancer.

Reducing the cancer burden

Between 30–50% of cancers can currently be prevented. This can be accomplished by avoiding risk factors and implementing existing evidence-based prevention strategies. The cancer burden can also be reduced through early detection of cancer and management of patients who develop cancer. Many cancers have a high chance of cure if diagnosed early and treated adequately.

Modify and avoid risk factors

Modifying or avoiding key risk factors can significantly reduce the burden of cancer. These risk factors include:

tobacco use including cigarettes and smokeless tobacco

being overweight or obese

unhealthy diet with low fruit and vegetable intake

lack of physical activity

alcohol use

sexually transmitted HPV-infection

infection by hepatitis or other carcinogenic infections

ionizing and ultraviolet radiation

urban air pollution

indoor smoke from household use of solid fuels.

Tobacco use is the single most important risk factor for cancer and is responsible for approximately 22% of cancer-related deaths globally.

Pursue prevention strategies

To prevent cancer, people may:

increase avoidance of the risk factors listed above;

vaccinate against HPV and hepatitis B virus;

control occupational hazards;

reduce exposure to ultraviolet radiation;

reduce exposure to ionizing radiation (occupational or medical diagnostic imaging).

Vaccination against these HPV and hepatitis B viruses could

prevent 1 million cancer cases

each year.

Early detection

Cancer mortality can be reduced if cases are detected and treated early. There are 2 components of early detection:

Early diagnosis

When identified early, cancer is more likely to respond to effective treatment and can result in a greater probability of surviving, less morbidity, and less expensive treatment. Significant improvements can be made in the lives of cancer patients by detecting cancer early and avoiding delays in care.

Early diagnosis consists of 3 steps that must be integrated and provided in a timely manner:

awareness and accessing care

clinical evaluation, diagnosis and staging

access to treatment.

Early diagnosis is relevant in all settings and the majority of cancers. In absence of early diagnosis, patients are diagnosed at late stages when curative treatment may no longer be an option. Programmes can be designed to reduce delays in, and barriers to, care, allowing patients to access treatment in a timely manner.


Screening aims to identify individuals with abnormalities suggestive of a specific cancer or pre-cancer who have not developed any symptoms and refer them promptly for diagnosis and treatment.

Screening programmes can be effective for select cancer types when appropriate tests are used, implemented effectively, linked to other steps in the screening process and when quality is assured. In general, a screening programme is a far more complex public health intervention compared to early diagnosis.

Examples of screening methods are:

visual inspection with acetic acid (VIA) for cervical cancer in low-income settings;

HPV testing for cervical cancer;

PAP cytology test for cervical cancer in middle- and high-income settings; and

mammography screening for breast cancer in settings with strong or relatively strong health systems.


A correct cancer diagnosis is essential for adequate and effective treatment because every cancer type requires a specific treatment regimen that encompasses one or more modalities such as surgery, radiotherapy, and chemotherapy. Determining the goals of treatment and palliative care is an important first step, and health services should be integrated and people-centred.

The primary goal is generally to cure cancer or to considerably prolong life. Improving the patient's quality of life is also an important goal. This can be achieved by supportive or palliative care and psychosocial support.

Potential for cure among early detectable cancers

Some of the most common cancer types, such as breast cancer, cervical cancer, oral cancer, and colorectal cancer have high cure rates when detected early and treated according to best practices.

Potential for cure of some other cancers

Some cancer types, even when cancerous cells have traveled to other areas of the body, such as testicular seminoma and leukaemias and lymphomas in children, can have high cure rates if appropriate treatment is provided.

Palliative care

Palliative care is treatment to relieve, rather than cure, symptoms caused by cancer and improve the quality of life of patients and their families. Palliative care can help people live more comfortably. It is an urgent humanitarian need for people worldwide with cancer and other chronic fatal diseases and particularly needed in places with a high proportion of patients in advanced stages of cancer where there is little chance of cure.

Relief from physical, psychosocial, and spiritual problems can be achieved in over 90% of

advanced cancer patients through palliative care.

Palliative care strategies

Effective public health strategies, comprising of community- and home-based care are essential to provide pain relief and palliative care for patients and their families in low-resource settings.

Improved access to oral morphine is mandatory for the treatment of moderate to severe cancer pain, suffered by over 80% of cancer patients in terminal phase.

WHO response

In 2013, WHO launched the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 that aims to reduce, by 25%, premature mortality from cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases by 2025.

WHO and IARC collaborate with other UN organizations within the UN Interagency Task Force on the Prevention and Control of Noncommunicable Diseases and partners to:

increase political commitment for cancer prevention and control;

coordinate and conduct research on the causes of human cancer and the mechanisms of carcinogenesis;

monitor the cancer burden (as part of the work of the Global Initiative on Cancer Registries);

identify priority strategies for cancer prevention and control;

generate new knowledge and disseminate existing knowledge to facilitate the delivery of evidence-based approaches to cancer control;

develop standards and tools to guide the planning and implementation of interventions for prevention, early diagnosis, screening, treatment and palliative and survivorship care;

facilitate broad networks of cancer control partners and experts at global, regional and national levels;

strengthen health systems at national and local levels to deliver cure and care for cancer patients;

provide global leadership as well as technical assistance to support governments and their partners build and sustain high-quality cervical cancer control programmes; and

provide technical assistance for rapid, effective transfer of best practice interventions to less-developed countries.



Most Viewed
Digital Edition
More story
From the Editor

From the Editor

The eye is the most vital of all the sense organs of humankind. Through the eye we can see the most precious of the gifts of God; this most bounteous…
Retinal disorders

Retinal disorders

The retina is the light-sensitive membrane on the inner surface of the back of the eye. The optic nerve extends from the brain to about the center of…


Glaucoma is a serious eye disease and a common cause of blindness. It is responsible for 20% of blindness in Singapore. Glaucoma is caused by damage to…


A cataract is a clouding of the eye's natural lens, which lies behind the iris and the pupil. The lens works much like a camera lens, focusing light…
Refractive disorders

Refractive disorders

Normally, the eye creates a clear image because the cornea and lens bend (refract) incoming light rays to focus them on the retina. The shape of the cornea…
Autoimmune response contributes to vision loss in glaucoma patients

Autoimmune response contributes to vision loss in glaucoma patients

A research team from Massachusetts Eye and Ear and MIT has shown that immune cells in the eye that developed in response to early exposure to bacteria…
How blue light from smartphones can speed up blindness

How blue light from smartphones can speed up blindness

Staring at your mobile phone or laptop could speed up blindness, according to scientists.   A new study by Toledo University in Ohio found that blue…
Guide to personality disorders

Guide to personality disorders

What is a personality disorder? These mental health conditions affect your everyday life and relationships. They’re about how you think, feel, and…
Preventing and treating non-
communicable diseases

Preventing and treating non- communicable diseases

We aim to assess the burden of non-communicable diseases (NCDs) in Bangladesh, document the epidemiology and risk factors of the most common NCDs, and…
Occupational therapy for Chiari Malformation (CM)

Occupational therapy for Chiari Malformation (CM)

Chiari malformation is a problem with the structures at the back of the brain. An area of the brain called the cerebellum normally sits inside the back…
Regular exercise 'best for mental health'

Regular exercise 'best for mental health'

Regular physical activity lasting 45 minutes three to five times a week can reduce poor mental health - but doing more than that is not always beneficial,…
Stem cells restore some vision in blind mice

Stem cells restore some vision in blind mice

Scientists say they have restored some degree of vision in blind lab mice, by activating stem cells in their eyes. The procedure is the first of its kind…
FDA approves Perseris (risperidone) for the treatment of schizophrenia in adults

FDA approves Perseris (risperidone) for the treatment of schizophrenia in adults

Indivior PLC recently announced that the U.S. Food and Drug Administration (FDA) has approved Perseris, the first once-monthly subcutaneous risperidone-containing,…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
About Us
Contact Us

Powered by : Frog Hosting